HIV News and Research

RSS

International consortium to accelerate collaborative multi-site trials of potential Ebola vaccine

A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.

29 Aug 2014

Health law provision seeks to rein in executive compensation at insurance companies

News outlets report that this little-noticed provision puts in place stricter limits regarding the amount companies can deduct from their federal tax bills. Also in the news, The Associated Press reports on ways health plans discourage sick people from enrolling and The New York Times examines the health law's efforts to expand mental health coverage.

28 Aug 2014

FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

Mylan Inc. today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration.

28 Aug 2014

First Edition: August 28, 2014

Today's headlines include reports about the Congressional Budget Office's latest projections regarding Medicare and Medicaid spending.

28 Aug 2014

Study: Many HIV infected African-Americans may not be receiving effective doses of maraviroc drug

Many African-Americans may not be getting effective doses of the HIV drug maraviroc, a new study from Johns Hopkins suggests. The initial dosing studies, completed before the drug was licensed in 2007, included mostly European-Americans, who generally lack a protein that is key to removing maraviroc from the body.

28 Aug 2014

Gang involvement poses serious health-related risks for African American girls

Being involved in a gang poses considerable health-related risks for adolescent African American girls, including more casual sex partners and substance abuse combined with less testing for HIV and less knowledge about preventing sexually transmitted diseases, according to a new study.

28 Aug 2014

University of Liverpool researchers identify pathogens that pose greater risk to people in Europe

The pathogens posing the greatest risk to Europe based upon a proxy for impact have been identified by University of Liverpool researchers using a 'big data' approach to scientific research.

28 Aug 2014

TIM-family proteins also have ability to block release of HIV and other viruses

A family of proteins that promotes virus entry into cells also has the ability to block the release of HIV and other viruses, University of Missouri researchers have found.

26 Aug 2014

BD announces winners of 2014 "Innovations in Care" awards

BD (Becton, Dickinson and Company), a leading global medical technology company – together with Direct Relief and the National Association of Community Health Centers – has announced the winners of the 2014 "Innovations in Care" awards to seven community health centers as part of the BD Helping Build Healthy CommunitiesSM initiative.

From BD (Becton, Dickinson and Company) 26 Aug 2014

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology platform.

25 Aug 2014

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

ViiV Healthcare announced today that the US Food and Drug Administration has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection.

23 Aug 2014

Mylan launches Potassium Chloride Extended-release Tablets

Mylan Inc. today announced that it has launched Potassium Chloride Extended-release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg), which is the generic version of Upsher-Smith's Klor-Con.

22 Aug 2014

Longer looks: Falling teen birth rate; the right to pain relief; limiting access to Sovaldi

An infectious disease doctor at Tulane University, [MarkAlain] Dery treats people living with HIV in New Orleans and Baton Rouge, the two largest cities in the southern state of Louisiana, which itself has the fourth-highest rate of HIV in the United States, just behind New York, Florida and Maryland.

22 Aug 2014

MRSA superbug control policies in hospitals lack evidence, say infectious disease experts

The jury is still out on the effectiveness of meticillin-resistant Staphylococcus aureus (MRSA) superbug control policies in hospitals, according to leading infectious disease experts in a Viewpoint published in The Lancet.

22 Aug 2014

Fungal infections that sicken HIV/AIDS patients grow on trees

Researchers have pinpointed the environmental source of fungal infections that have been sickening HIV/AIDS patients in Southern California for decades. It literally grows on trees.

22 Aug 2014

Baxter reports positive results from BAX 855 Phase 3 trial for hemophilia A

Nektar Therapeutics reports Baxter International Inc. today announced positive results from its Phase 3 pivotal clinical trial of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)], which met its primary endpoint in reducing annualized bleed rates (ABR) in the prophylaxis arm compared to the on-demand arm.

From Baxter International Inc. 22 Aug 2014

Prenatal care for pregnant women increases from 61 to 91.3%, highlights Equatorial Guinea

Equatorial Guinea's infant mortality rate has decreased from 111 in 1994 to 65 per one thousand in 2011, said the country's Health Secretary of State, Maria del Carmen Andeme Ela. She also reported that the percentage of pregnant women receiving prenatal care from skilled health personnel has increase from 61% in 2000 to 91.3% this year.

22 Aug 2014

HIV News and Research

International consortium to accelerate collaborative multi-site trials of potential Ebola vaccine

Health law provision seeks to rein in executive compensation at insurance companies

FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

First Edition: August 28, 2014

Study: Many HIV infected African-Americans may not be receiving effective doses of maraviroc drug

Gang involvement poses serious health-related risks for African American girls

University of Liverpool researchers identify pathogens that pose greater risk to people in Europe

TIM-family proteins also have ability to block release of HIV and other viruses

BD announces winners of 2014 "Innovations in Care" awards

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

Mylan launches Potassium Chloride Extended-release Tablets

Longer looks: Falling teen birth rate; the right to pain relief; limiting access to Sovaldi

MRSA superbug control policies in hospitals lack evidence, say infectious disease experts

Fungal infections that sicken HIV/AIDS patients grow on trees

Baxter reports positive results from BAX 855 Phase 3 trial for hemophilia A

Prenatal care for pregnant women increases from 61 to 91.3%, highlights Equatorial Guinea

Research: Seals and sea lions may spread tuberculosis to humans

Some states angered about lack of authority over Medicare advantage plans

Study: Patients with 2 or more ED visits in one year account for disproportionate costs

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News